353 related articles for article (PubMed ID: 6230400)
1. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.
Sacks DL; Scott PA; Asofsky R; Sher FA
J Immunol; 1984 Apr; 132(4):2072-7. PubMed ID: 6230400
[TBL] [Abstract][Full Text] [Related]
2. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis.
Scott P; Natovitz P; Sher A
J Immunol; 1986 Aug; 137(3):1017-21. PubMed ID: 3487581
[TBL] [Abstract][Full Text] [Related]
3. B cell-deprived mice lack functional expression of certain T suppressor cell subsets.
Flood PM; Janeway CA; Gershon RK
J Mol Cell Immunol; 1984; 1(3):167-76. PubMed ID: 6242856
[TBL] [Abstract][Full Text] [Related]
4. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
Liew FY; Hale C; Howard JG
J Immunol; 1982 Apr; 128(4):1917-22. PubMed ID: 6120976
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
Liew FY; Singleton A; Cillari E; Howard JG
J Immunol; 1985 Sep; 135(3):2102-7. PubMed ID: 3160786
[TBL] [Abstract][Full Text] [Related]
6. T cell development in B cell deficient mice. III. Restriction specificity of suppressor T cell factor(s) produced in mice treated chronically with rabbit anti-mouse mu chain antibody.
HayGlass KT; Naides SJ; Benacerraf B; Sy MS
J Mol Cell Immunol; 1985; 2(2):107-17. PubMed ID: 2978459
[TBL] [Abstract][Full Text] [Related]
7. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
Belosevic M; Finbloom DS; Van Der Meide PH; Slayter MV; Nacy CA
J Immunol; 1989 Jul; 143(1):266-74. PubMed ID: 2499629
[TBL] [Abstract][Full Text] [Related]
8. The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice.
Kurt-Jones EA; Liano D; HayGlass KA; Benacerraf B; Sy MS; Abbas AK
J Immunol; 1988 Jun; 140(11):3773-8. PubMed ID: 2453554
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated allotype suppression in adult mice: the role of antigen, effector isotype and regulatory T cells.
Curling EM; Dresser DW
Eur J Immunol; 1984 Oct; 14(10):865-70. PubMed ID: 6237917
[TBL] [Abstract][Full Text] [Related]
10. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
Liew FY; Dhaliwal JS
J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
[TBL] [Abstract][Full Text] [Related]
11. Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation.
Basak SK; Saha B; Bhattacharya A; Roy S
Eur J Immunol; 1992 Aug; 22(8):2041-5. PubMed ID: 1386313
[TBL] [Abstract][Full Text] [Related]
12. Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population.
Finkelman FD; Mond JJ; Metcalf ES
J Immunol; 1983 Aug; 131(2):593-600. PubMed ID: 6602840
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
Liew FY; Howard JG; Hale C
J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
[TBL] [Abstract][Full Text] [Related]
14. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody.
Hamano T; Leiserson WM; Asofsky R
J Immunol; 1983 Jul; 131(1):98-102. PubMed ID: 6408183
[TBL] [Abstract][Full Text] [Related]
15. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
Moll H; Scollay R
Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
[TBL] [Abstract][Full Text] [Related]
16. Cell-associated IgM, but not IgD or I-A/E, is important in the activation of suppressor T cells by antigen-primed B cells.
Elkins KL; Stashak PW; Baker PJ
J Immunol; 1987 Aug; 139(3):695-701. PubMed ID: 2955049
[TBL] [Abstract][Full Text] [Related]
17. Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. II. Anti-mu treatment affects the initiation and recruitment of T cells.
Ron Y; De Baetselier P; Tzehoval E; Gordon J; Feldman M; Segal S
Eur J Immunol; 1983 Feb; 13(2):167-71. PubMed ID: 6403358
[TBL] [Abstract][Full Text] [Related]
18. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate.
Hashimoto N; Takatsu K; Masuho Y; Kishida K; Hara T; Hamaoka T
J Immunol; 1984 Jan; 132(1):129-35. PubMed ID: 6418795
[TBL] [Abstract][Full Text] [Related]
19. Functional studies on B cell hybridomas with B cell surface antigens. IV. Direct effects of cytochalasin B on differentiation.
Hamano T; Asofsky R
J Immunol; 1984 Jan; 132(1):122-8. PubMed ID: 6418794
[TBL] [Abstract][Full Text] [Related]
20. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
George AJ; Tutt AL; Stevenson FK
J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
